{"id":"https://openalex.org/W2122815596","doi":"https://doi.org/10.1093/annonc/mdq708","title":"Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer","display_name":"Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer","publication_year":2011,"publication_date":"2011-01-27","ids":{"openalex":"https://openalex.org/W2122815596","doi":"https://doi.org/10.1093/annonc/mdq708","mag":"2122815596","pmid":"https://pubmed.ncbi.nlm.nih.gov/21273348"},"language":"en","primary_location":{"id":"doi:10.1093/annonc/mdq708","doi":"https://doi.org/10.1093/annonc/mdq708","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdq708","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.1093/annonc/mdq708","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5042305043","display_name":"Martin Zweifel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108939","display_name":"Mount Vernon Cancer Centre","ror":"https://ror.org/01wwv4x50","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210108939","https://openalex.org/I4210122718"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M. Zweifel","raw_affiliation_strings":["Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood","institution_ids":["https://openalex.org/I4210108939"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023247842","display_name":"Gordon C. Jayson","orcid":"https://orcid.org/0000-0002-8515-8944","observed_orcids":["https://orcid.org/0000-0002-8515-8944"]},"institutions":[{"id":"https://openalex.org/I28407311","display_name":"University of Manchester","ror":"https://ror.org/027m9bs27","country_code":"GB","type":"education","lineage":["https://openalex.org/I28407311"]},{"id":"https://openalex.org/I4210131968","display_name":"The Christie Hospital","ror":"https://ror.org/03nd63441","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210131968","https://openalex.org/I4210133995"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G.C. Jayson","raw_affiliation_strings":["School of Cancer and Enabling Sciences, University of Manchester & Christie Hospital, Manchester","School of Cancer and Enabling Sciences, University of Manchester and Christie Hospital, Manchester"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Cancer and Enabling Sciences, University of Manchester & Christie Hospital, Manchester","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210131968"]},{"raw_affiliation_string":"School of Cancer and Enabling Sciences, University of Manchester and Christie Hospital, Manchester","institution_ids":["https://openalex.org/I28407311","https://openalex.org/I4210131968"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109140215","display_name":"N.S. Reed","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800373718","display_name":"Beatson West of Scotland Cancer Centre","ror":"https://ror.org/03pp86w19","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800373718"]},{"id":"https://openalex.org/I2801120601","display_name":"Western Infirmary","ror":"https://ror.org/02e22bh87","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800201399","https://openalex.org/I2801120601"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"N.S. Reed","raw_affiliation_strings":["Beatson Oncology Centre, Western Infirmary, Glasgow"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beatson Oncology Centre, Western Infirmary, Glasgow","institution_ids":["https://openalex.org/I2800373718","https://openalex.org/I2801120601"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059234240","display_name":"Richard H. Osborne","orcid":"https://orcid.org/0000-0002-9081-2699","observed_orcids":["https://orcid.org/0000-0002-9081-2699"]},"institutions":[{"id":"https://openalex.org/I4210136519","display_name":"Poole Hospital NHS Foundation Trust","ror":"https://ror.org/03kdm3q80","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210136519","https://openalex.org/I4387155041"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"R. Osborne","raw_affiliation_strings":["Dorset Cancer Centre, Poole Hospital NHS Foundation Trust, Poole"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dorset Cancer Centre, Poole Hospital NHS Foundation Trust, Poole","institution_ids":["https://openalex.org/I4210136519"]}]},{"author_position":"middle","author":{"id":null,"display_name":"B. Hassan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801179840","display_name":"Churchill Hospital","ror":"https://ror.org/009vheq40","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801179840","https://openalex.org/I4210147381"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"B. Hassan","raw_affiliation_strings":["Department of Medical Oncology, Churchill Hospital, Oxford"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Churchill Hospital, Oxford","institution_ids":["https://openalex.org/I2801179840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079383798","display_name":"Jonathan Andrew Ledermann","orcid":"https://orcid.org/0000-0003-3799-3539","observed_orcids":["https://orcid.org/0000-0003-3799-3539"]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. Ledermann","raw_affiliation_strings":["UCL Cancer Institute, Cancer Research UK & University College of London Cancer Trials Centre, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCL Cancer Institute, Cancer Research UK & University College of London Cancer Trials Centre, London, UK","institution_ids":["https://openalex.org/I2801316944","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061979892","display_name":"Gavin Shreeves","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108939","display_name":"Mount Vernon Cancer Centre","ror":"https://ror.org/01wwv4x50","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210108939","https://openalex.org/I4210122718"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G. Shreeves","raw_affiliation_strings":["Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood","institution_ids":["https://openalex.org/I4210108939"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048953130","display_name":"L. Poupard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108939","display_name":"Mount Vernon Cancer Centre","ror":"https://ror.org/01wwv4x50","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210108939","https://openalex.org/I4210122718"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"L. Poupard","raw_affiliation_strings":["Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood","institution_ids":["https://openalex.org/I4210108939"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111920106","display_name":"S.-P. Lu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S.-P. Lu","raw_affiliation_strings":["OXiGENE Inc., San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OXiGENE Inc., San Francisco, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110532843","display_name":"Jai Balkissoon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Balkissoon","raw_affiliation_strings":["OXiGENE Inc., San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OXiGENE Inc., San Francisco, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111866561","display_name":"David J. Chaplin","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D.J. Chaplin","raw_affiliation_strings":["OXiGENE Inc., San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OXiGENE Inc., San Francisco, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047753094","display_name":"Gordon J.S. Rustin","orcid":"https://orcid.org/0000-0002-2749-5467","observed_orcids":["https://orcid.org/0000-0002-2749-5467"]},"institutions":[{"id":"https://openalex.org/I4210108939","display_name":"Mount Vernon Cancer Centre","ror":"https://ror.org/01wwv4x50","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210108939","https://openalex.org/I4210122718"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"G.J.S. Rustin","raw_affiliation_strings":["Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood. Electronic address: grustin@nhs.net","Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood. Electronic address: grustin@nhs.net","institution_ids":["https://openalex.org/I4210108939"]},{"raw_affiliation_string":"Department of Medical Oncology, Mount Vernon Cancer Centre, Northwood","institution_ids":["https://openalex.org/I4210108939"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5047753094"],"corresponding_institution_ids":["https://openalex.org/I4210108939"],"apc_list":{"value":5080,"currency":"USD","value_usd":5080},"apc_paid":null,"fwci":7.2975,"has_fulltext":false,"cited_by_count":163,"citation_normalized_percentile":{"value":0.98157257,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"22","issue":"9","first_page":"2036","last_page":"2041"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/combretastatin-a4-phosphate","display_name":"combretastatin A4 phosphate","score":0.9940000176429749},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.9210000038146973},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":1.0},{"id":"https://openalex.org/keywords/platinum-resistant-ovarian-cancer","display_name":"platinum-resistant ovarian cancer","score":0.9049999713897705},{"id":"https://openalex.org/keywords/recurrent-ovarian-cancer","display_name":"recurrent ovarian cancer","score":0.9549999833106995},{"id":"https://openalex.org/keywords/vascular-disrupting-agents","display_name":"vascular disrupting agents","score":0.9660000205039978},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7620000243186951},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.6570000052452087},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.9520000219345093},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.6340000033378601},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.38600000739097595}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9523701071739197},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.9389934539794922},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.6728879809379578},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.665837824344635},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6439675688743591},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.5733989477157593},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5041855573654175},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4965558648109436},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3589378595352173},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.32860076427459717},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.24158477783203125}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009944","descriptor_name":"Organoplatinum Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010051","descriptor_name":"Ovarian Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013267","descriptor_name":"Stilbenes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D013267","descriptor_name":"Stilbenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1093/annonc/mdq708","doi":"https://doi.org/10.1093/annonc/mdq708","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdq708","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},{"id":"pmid:21273348","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21273348","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of oncology : official journal of the European Society for Medical Oncology","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1363528","doi":null,"is_oa":false,"landing_page_url":"http://discovery.ucl.ac.uk/1363528/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ANNALS OF ONCOLOGY , 22 (9) pp. 2036-2041. (2011)","raw_type":"Article"},{"id":"pmh:oai:open-archive.highwire.org:annonc:mdq708v1","doi":null,"is_oa":false,"landing_page_url":"http://annonc.oxfordjournals.org/cgi/content/short/mdq708v1","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/1ae245e8-a56e-4c22-ad8c-66c3b6c5d628","doi":null,"is_oa":false,"landing_page_url":"https://research.manchester.ac.uk/en/publications/1ae245e8-a56e-4c22-ad8c-66c3b6c5d628","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Zweifel, M, Jayson, G C, Reed, N S, Osborne, R, Hassan, B, Ledermann, J, Shreeves, G, Poupard, L, Lu, S P, Balkissoon, J, Chaplin, D J & Rustin, G J S 2011, 'Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer', Annals of Oncology, vol. 22, no. 9, pp. 2036-2041. https://doi.org/10.1093/annonc/mdq708","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1093/annonc/mdq708","doi":"https://doi.org/10.1093/annonc/mdq708","is_oa":true,"landing_page_url":"https://doi.org/10.1093/annonc/mdq708","pdf_url":null,"source":{"id":"https://openalex.org/S41454044","display_name":"Annals of Oncology","issn_l":"0923-7534","issn":["0923-7534","1569-8041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W1913802169","https://openalex.org/W1960327677","https://openalex.org/W1976128207","https://openalex.org/W1984829593","https://openalex.org/W2024264494","https://openalex.org/W2024304301","https://openalex.org/W2029409133","https://openalex.org/W2033561964","https://openalex.org/W2034034974","https://openalex.org/W2044421413","https://openalex.org/W2056944384","https://openalex.org/W2072697228","https://openalex.org/W2074699898","https://openalex.org/W2097265582","https://openalex.org/W2105412427","https://openalex.org/W2117729836","https://openalex.org/W2128186312","https://openalex.org/W2129949847","https://openalex.org/W2133506440","https://openalex.org/W2136753100","https://openalex.org/W2138539226","https://openalex.org/W2139248078","https://openalex.org/W2152961487","https://openalex.org/W2154885792","https://openalex.org/W2171391552","https://openalex.org/W2222529560","https://openalex.org/W2234488796","https://openalex.org/W2561967435","https://openalex.org/W6685191938"],"related_works":["https://openalex.org/W2249816860","https://openalex.org/W2200931786","https://openalex.org/W2024264494","https://openalex.org/W2141193461","https://openalex.org/W2125904513","https://openalex.org/W2400821810","https://openalex.org/W2106164555","https://openalex.org/W2406157896","https://openalex.org/W2086317851","https://openalex.org/W2137920066"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":13},{"year":2017,"cited_by_count":17},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":14},{"year":2012,"cited_by_count":14}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}